About this document
Evobrutinib vs Teriflunomide in MS Trials by busraisci61 is a document available to read on EtoBox.
The phase 3 trials evolutionRMS1 and evolutionRMS2 evaluated the safety and efficacy of evobrutinib, a BTK inhibitor, compared to teriflunomide in patients with relapsing multiple sclerosis. Results indicated that evobrutinib did not demonstrate superior efficacy over teriflunomide, and safety findings, particularly concerning liver-related adverse events, do not support its use in this patient population. The studies involved 2290 participants across 701 centers in 52 countries, with findings suggesting th
- Author
- busraisci61
- Language
- EN